Published in Pharmacoepidemiol Drug Saf on July 28, 2011
QT interval and antidepressant use: a cross sectional study of electronic health records. BMJ (2013) 1.40
Implementation of warnings from Dear Doctor Letters (Rote-Hand-Briefe): an analysis of medication data from a large cohort of elderly patients. Dtsch Arztebl Int (2014) 1.04
Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study. BMJ (2012) 1.00
Blockade of Kv1.5 channels by the antidepressant drug sertraline. Korean J Physiol Pharmacol (2016) 0.84
Clinical use of antidepressant therapy and associated cardiovascular risk. Drug Healthc Patient Saf (2012) 0.83
Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database. BMJ (2016) 0.78
Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010. Int J Neuropsychopharmacol (2014) 0.78
Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults - a Swedish nationwide study. Br J Clin Pharmacol (2016) 0.77
Risk of Ventricular Arrhythmia with Citalopram and Escitalopram: A Population-Based Study. PLoS One (2016) 0.75
Cardiovascular considerations in antidepressant therapy: an evidence-based review. J Tehran Heart Cent (2013) 0.75
Factors Associated With Musculoskeletal Injuries in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. Prim Care Companion CNS Disord (2016) 0.75
Reconciling the risk of QT interval prolongation in antidepressants. Pharmacoepidemiol Drug Saf (2012) 0.75
Antidepressant Use and Subclinical Measures of Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis. J Clin Psychopharmacol (2016) 0.75
Lack of relationship between plasma levels of escitalopram and QTc-interval length. Eur Arch Psychiatry Clin Neurosci (2017) 0.75
Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol (2004) 4.44
Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch Intern Med (2005) 2.73
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ (2002) 2.46
Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ (2010) 2.40
Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine. Am J Cardiol (1994) 2.14
State-specific mortality from sudden cardiac death--United States, 1999. MMWR Morb Mortal Wkly Rep (2002) 2.10
Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol (2004) 1.86
Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf (2010) 1.78
Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther (2004) 1.67
Quality of Medicaid and Medicare data obtained through Centers for Medicare and Medicaid Services (CMS). Med Care (2007) 1.66
Validation of death certificate diagnosis of out-of-hospital sudden cardiac death. Am J Cardiol (1998) 1.48
The safety profile of paroxetine. J Clin Psychiatry (1992) 1.47
Genomics in sudden cardiac death. Circ Res (2004) 1.42
Out-of-hospital cardiac arrest in men and women. Circulation (2001) 1.39
Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA (1998) 1.38
The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada. Am J Med (1999) 1.33
Sudden cardiac death secondary to antidepressant and antipsychotic drugs. Expert Opin Drug Saf (2008) 1.30
Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States. Pharmacoepidemiol Drug Saf (2002) 1.16
A comparison of death certificate out-of-hospital coronary heart disease death with physician-adjudicated sudden cardiac death. Am J Cardiol (2005) 1.16
Psychotropic drugs and the ECG: focus on the QTc interval. Expert Opin Pharmacother (2002) 1.11
Psychotropic drugs associated with corrected QT interval prolongation. J Clin Psychopharmacol (2009) 1.05
Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes. Curr Opin Investig Drugs (2006) 1.00
Out-of-hospital sudden death referring to an emergency department. J Clin Epidemiol (1996) 0.97
Disenrollment from Medicaid after recent cancer diagnosis. Med Care (2008) 0.95
Association of antipsychotic and antidepressant drugs with Q-T interval prolongation. Am J Health Syst Pharm (2008) 0.91
Electrophysiological changes of cardiac function during antidepressant treatment. Ther Adv Cardiovasc Dis (2008) 0.91
The cardiovascular effects of bupropion and nortriptyline in depressed outpatients. Ann Clin Psychiatry (1994) 0.90
Survivors of prehospital cardiac arrest. JAMA (1982) 0.88
Effect of paroxetine on the electrocardiogram. Psychopharmacology (Berl) (1989) 0.88
Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men. J Clin Psychopharmacol (1997) 0.84
Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder. Depress Anxiety (2000) 0.84
Comparison of the effects of bupropion and amitriptyline on cardiac conduction in depressed patients. J Clin Psychiatry (1983) 0.84
Outcomes after ventricular fibrillation out-of-hospital cardiac arrest: expanding the chain of survival. Mayo Clin Proc (2005) 0.84
Prediction of short- and long-term outcomes by electrocardiography in survivors of out-of-hospital cardiac arrest. Resuscitation (2004) 0.80
Cardiovascular effects of paroxetine. Psychopharmacology (Berl) (1990) 0.79
Role of computerized physician order entry systems in facilitating medication errors. JAMA (2005) 26.32
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care (2011) 5.63
The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis (2010) 5.34
Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med (2003) 5.09
Design of a national distributed health data network. Ann Intern Med (2009) 4.09
Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation (2010) 3.78
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology (2004) 3.57
Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial. Arch Intern Med (2010) 3.31
The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf (2005) 3.24
Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med (2012) 3.08
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood (2010) 2.93
Clinical risk factors for primary graft failure following lung transplantation. Chest (2003) 2.92
The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf (2012) 2.70
Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am J Psychiatry (2003) 2.69
Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int (2010) 2.59
The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med (2005) 2.57
A cognitive neuroscience-based computerized battery for efficient measurement of individual differences: standardization and initial construct validation. J Neurosci Methods (2009) 2.55
Age group and sex differences in performance on a computerized neurocognitive battery in children age 8-21. Neuropsychology (2012) 2.54
Hemodynamics and survival of patients with portopulmonary hypertension. Liver Transpl (2005) 2.53
Retrospective drug utilization review, prescribing errors, and clinical outcomes. JAMA (2003) 2.51
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ (2002) 2.46
Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol (2002) 2.39
Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol (2011) 2.36
A test of financial incentives to improve warfarin adherence. BMC Health Serv Res (2008) 2.23
Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf (2002) 2.12
Differences in facial expressions of four universal emotions. Psychiatry Res (2004) 2.11
Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. J Am Coll Cardiol (2011) 2.09
Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation (2003) 2.07
Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation (2009) 2.06
Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch Intern Med (2003) 2.02
Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction. Circ Heart Fail (2011) 2.01
Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med (2008) 1.99
Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. J Infect Dis (2006) 1.96
Impact of primary graft failure on outcomes following lung transplantation. Chest (2005) 1.92
Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest (2003) 1.90
Medication adherence: a call for action. Am Heart J (2011) 1.85
Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infect Control Hosp Epidemiol (2009) 1.85
Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant (2010) 1.85
Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics (2011) 1.84
Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis (2004) 1.83
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med (2005) 1.82
Immunosuppressant medications and mortality in inflammatory bowel disease. Am J Gastroenterol (2008) 1.80
Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf (2010) 1.78
Quality of care indicators for gout management. Arthritis Rheum (2004) 1.77
Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol (2006) 1.76
Cyclosporine for ocular inflammatory diseases. Ophthalmology (2010) 1.75
The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysis. J Am Coll Cardiol (2006) 1.72
Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial. Trials (2010) 1.72
On the estimation and use of propensity scores in case-control and case-cohort studies. Am J Epidemiol (2007) 1.71
Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance. Infect Control Hosp Epidemiol (2005) 1.71
Telling truth from lie in individual subjects with fast event-related fMRI. Hum Brain Mapp (2005) 1.70
Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure. J Card Fail (2011) 1.70
Sex differences in temporo-limbic and frontal brain volumes of healthy adults. Cereb Cortex (2002) 1.69
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst (2012) 1.69
Quality of Medicaid and Medicare data obtained through Centers for Medicare and Medicaid Services (CMS). Med Care (2007) 1.66
Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia. Arch Gen Psychiatry (2007) 1.65
Health care for older Americans with multiple chronic conditions: a research agenda. J Am Geriatr Soc (2007) 1.65
Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures. Schizophr Bull (2006) 1.64
Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol (2013) 1.64
Reemergence of gram-negative health care-associated bloodstream infections. Arch Intern Med (2006) 1.63
Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial. Stroke (2002) 1.62
Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: a prospective randomized study. Heart Rhythm (2007) 1.59
Long-term effects of culture of preimplantation mouse embryos on behavior. Proc Natl Acad Sci U S A (2004) 1.57
Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004. JAMA (2008) 1.57
Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure. Circulation (2009) 1.55
Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab (2004) 1.55
Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study. PLoS One (2011) 1.54
Location, location, location: geographic clustering of lower-extremity amputation among Medicare beneficiaries with diabetes. Diabetes Care (2011) 1.54
Identifying potential adverse effects using the web: a new approach to medical hypothesis generation. J Biomed Inform (2011) 1.52
Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact. Am J Med (2006) 1.47
Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J (2004) 1.45
Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS (2002) 1.44
Represcription of penicillin after allergic-like events. J Allergy Clin Immunol (2004) 1.44
Genetic warfarin dosing: tables versus algorithms. J Am Coll Cardiol (2011) 1.43
Methylphenidate and risk of serious cardiovascular events in adults. Am J Psychiatry (2012) 1.42
Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy. Infect Control Hosp Epidemiol (2006) 1.42
Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure. J Card Fail (2013) 1.41
Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Clin Infect Dis (2005) 1.39
Descriptive analyses of the integrity of a US Medicaid claims database. Pharmacoepidemiol Drug Saf (2003) 1.38
Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction. Am J Cardiol (2004) 1.38
Is improved survival a class effect of angiotensin-converting enzyme inhibitors? Ann Intern Med (2004) 1.35
Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Clin Infect Dis (2005) 1.35
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. Thromb Haemost (2011) 1.35
Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study. J Gen Intern Med (2007) 1.35